Advertisements

Fuci Top 2%

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Fuci Top 2%

Quick Facts

Property Description
Active ingredient Fusidic Acid
Form Cream or Ointment (Topical)
Pharmacological class Antibiotic (Fusidane Class)
Common use Addressing bacterial skin problems
Origin Derived from the fungus Fusidium coccineum

What Type of Medicine is Fuci Top 2%?

Fuci Top 2% is a topical pharmaceutical preparation classified as an antibiotic and anti-infective drug intended solely for external use on the skin. Its active component is Fusidic Acid, and the 2% designation confirms the specific, often maximal, concentration of the medicine within the base formulation, which may be presented as a cream or an ointment. This product is typically a monotherapy, containing only the one primary medicinal ingredient, unlike certain other formulations which may feature additional compounds. Fusidic Acid is clinically recognized as highly effective against common skin pathogens.

Fuci Top 2% belongs to the unique fusidane class of antibiotics. Its active ingredient, Fusidic Acid, is structurally distinct, being classified as a steroidal antibiotic. The substance is derived from a natural source, specifically the fungus Fusidium coccineum. The distinct chemical structure of Fusidic Acid sets it apart from more conventional antibiotic families, such as the penicillins or macrolides, contributing to its specific activity profile against targeted bacterial strains. The drug is consistently identified as an anti-infective agent for dermatological use, supported by extensive pharmacological studies.


What is the General Purpose of This Topical Antibiotic?

The general purpose of Fuci Top 2% is to resolve bacterial skin problems by controlling the population of susceptible bacteria directly at the site of application. It functions through a bacteriostatic action, meaning its core principle is to halt the growth and reproduction of the target microorganisms. A typical use scenario involves topical application to an area of skin that shows signs of localized bacterial presence. It achieves this by selectively interfering with bacterial protein synthesis, a mechanism that prevents the bacteria from replicating and growing. By stopping the bacteria from proliferating, the preparation allows the body’s natural immune system to successfully clear the remaining infection, thereby restoring the skin to a healthy condition.

Advertisements

What side effects are possible with Fuci Top 2%?

Possible Side Effects and Safety Information

The safety profile of Fuci Top 2% is primarily structured around reactions at the application site, as detailed in official regulatory documents. Systemic absorption following topical use is generally considered negligible, limiting the risk of internal adverse effects.


Documented Adverse Reactions

The majority of documented reactions are local and dermatological. The official frequency categories for possible side effects include Uncommon (occurring in ge 1/1,000 to < 1/100 patients) and Rare (occurring in ge 1/10,000 to < 1/1,000 patients).

Key adverse reactions, classified under Skin and subcutaneous tissue disorders and General disorders and administration site conditions, include:

Classification Examples of Reactions
Uncommon Pruritus (itching), erythema (redness), rash, application site irritation or pain, burning sensation.
Rare Urticaria (hives), blister, contact dermatitis, eczema, hypersensitivity.

Serious manifestations of hypersensitivity are documented, including Angioedema (swelling that can affect the face or throat) and, very rarely, Anaphylaxis. These are classified under Immune system disorders.


Safety Considerations and Restrictions

Official labeling notes constraints related to the application and duration of use:

  • Administration Restriction: The product must avoid contact with the eyes due to the potential for conjunctival irritation.
  • Duration Risk: Prolonged or recurrent use is officially stated to increase the risk of developing antibiotic resistance and may lead to contact sensitization.
  • Special Populations: Due to negligible systemic exposure, specific warnings for patients with renal or hepatic impairment are not generally required for the topical formulation. Safety information advises that use during breast-feeding should avoid application to the breast area.

This structure establishes that the most common risks are local skin reactions, while underscoring the importance of adhering to duration limits to mitigate the risk of resistance.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The regulatory documents for Fuci Top 2% (Topical Fusidic Acid) state that an overdose is unlikely to occur due to the intended route of administration. Because the product is applied externally, the quantity of medicine absorbed into the body is minimal.


Documented Overdose Risk and Presentation

Accidental ingestion of the cream or ointment is generally unlikely to cause any harm to adults or older children. Regulatory assessments indicate that the total amount of active ingredient in a standard tube typically does not exceed the approved total daily oral dose for most individuals. Furthermore, the concentration of inactive ingredients (excipients) is also assessed as too low to constitute a safety risk. No specific, severe clinical manifestations are documented for overdose with the topical formulation.


When to Seek Help

If an excessive amount of the cream is applied or accidentally swallowed, and the person notices any effect or is worried, the official advice is to contact a doctor or pharmacist for guidance.

Mandatory Contact: A doctor must be contacted if the product is accidentally swallowed by an infant, specifically a child aged less than 1 year and weighing le10 kg. This mandatory action is due to the population-specific note that in this small cohort, the ingested dose may exceed the systemic therapeutic threshold. Overdose management is primarily directed towards the alleviation of symptoms.

Advertisements

Therapeutic Uses of Fuci Top 2%

What Fuci Top 2% Treats: Main Uses and Benefits

Fuci Top 2% is applied in addressing conditions where supportive symptom management for localized bacterial infections on the skin is needed. It contributes to easing the overall symptom load by controlling susceptible pathogens and managing associated symptoms.

This medicine is commonly used to help with infections caused by strains of Staphylococcus aureus and other sensitive bacteria. It is generally applied in clinical settings that involve acute or disruptive symptom patterns, generally used to help with primary infections such as impetigo, folliculitis, and bacterial complications like paronychia (nail fold infection). The treatment provides the supportive relief that helps patients cope more steadily and may assist with controlling the localized nature of the infection.


Targeting Key Symptom Clusters

Fuci Top 2% is considered relevant when short-term symptomatic assistance is needed for secondary infections that complicate existing skin conditions, for example, when patches of eczema or minor cuts and abrasions develop bacterial colonization. This application helps address symptom clusters that may become intense or disruptive during symptomatic periods. It is relevant for easing symptoms related to inflammatory or irritative states such as localized redness, swelling, weeping, and crusting of skin lesions.

Quick Fact: Relief for Localized Discomfort
Symptom Pattern Symptoms related to inflammatory or irritative states.
Therapeutic Benefit Supports improved day-to-day comfort and supports general well-being during symptomatic phases.
Context of Use Conditions involving acute or episodic bacterial presence on the skin.
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Fuci Top 2% — Official Regulatory Information

The eligibility for Fuci Top 2% (Topical Fusidic Acid 2%) is primarily determined by regulatory labeling focusing on contraindications and specific population cautions.


Category Official Regulatory Statement
Populations for whom use is allowed Adults and Children are permitted to use the medicine under standard labeled conditions.
Populations for whom use is contraindicated Patients with known hypersensitivity to the active substance, Fusidic Acid/Sodium Fusidate, or to any of the product’s excipients (e.g., Cetyl alcohol, Potassium sorbate, Butylhydroxyanisole).
Age-related eligibility rules Use is permitted in children and adolescents. Some local guidelines may specify a minimum age limit (e.g., over 1 or 2 years) for certain treatment protocols.
Pregnancy and lactation eligibility status Pregnancy: Use can be used; no adverse effects are anticipated due to negligible systemic exposure.
Eligibility-related restrictions Breastfeeding women: Use is permitted, but it is recommended to avoid applying the medicine on the breast to prevent accidental infant ingestion.

The official eligibility profile establishes hypersensitivity as the single absolute contraindication. Beyond this primary exclusion, the medicine is broadly permitted for use in all age groups (adults, adolescents, and children). Regulatory documents confirm that use is acceptable during pregnancy and breastfeeding because systemic absorption is minimal; however, specific caution is advised to prevent exposure to the breast area during lactation.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Fuci Top 2% is primarily determined by its topical route of administration and the resulting systemic absorption, as documented by official regulatory bodies.

Official Regulatory Interaction Status

The fundamental finding across regulatory documents is that systemic exposure to topically applied Fusidic Acid is considered negligible. This classification dictates the regulatory approach to documenting potential interactions with other medicinal products.

Category Official Regulatory Statement for Topical Fuci Top 2%
Systemic Interaction Risk Interactions with systemically administered medicinal products are considered minimal or negligible.
Interaction Studies Regulatory documentation states that no dedicated interaction studies have been performed for the topical cream or ointment.
Contraindications/Restrictions No specific drug–drug combinations are listed as formally contraindicated due to the low absorption profile.
Food/Alcohol Interactions No specific restrictions are documented for co-administration with food, alcohol, herbal products, or nutritional supplements.

Resulting Interaction Structure

Official labeling asserts that the minimal systemic exposure means that clinically significant pharmacokinetic or pharmacodynamic interactions with other systemic medicines are not anticipated. Consequently, regulatory documents do not mandate any specific timing rules, co-administration prohibitions, or population-specific interaction cautions for the topical preparation.

Advertisements

Mechanism of Action

How Fuci Top 2% Works: The Pharmacodynamic Mechanism

Targeted Inhibition of Bacterial Growth Machinery

Fusidic Acid targets the bacterial enzyme Elongation Factor G (EF-G) when it is complexed with the 70S ribosome. The molecule acts as a specific inhibitor by stabilizing this complex after GTP hydrolysis, creating a molecular lock that prevents EF-G from dissociating. This arrests the process of translocation, halting the assembly of polypeptide chains. The resulting bacteriostatic effect stops the proliferation of susceptible bacteria, relying on subsequent host-mediated removal.

Modulation of Local Inflammation Signaling

Beyond its antibacterial role, the drug exerts a parallel modulating effect on local immune cells. This secondary mechanism influences the body's physiological response by suppressing the activation of T-lymphocytes and reducing the release of pro-inflammatory cytokines at the application site. The resulting physiological change is the modulation of localized edema and erythema caused by inflammation. This mechanism integrates with the primary bacteriostatic action.

Mechanistic Constraints and Target Protection

The inhibitory lock is constrained by bacterial resistance mechanisms that compromise its action. This occurs when bacteria acquire genes (like fusB or fusC) that express protective proteins, which displace the drug-locked EF-G. This target-protection mechanism bypasses the intended action, allowing the bacteria to resume protein synthesis and growth, leading to the inability to sustain the bacteriostatic effect.

Advertisements

Dosage and Administration Information

The general principles for using Fuci Top 2%, a topical antibiotic, are established to ensure consistent administration. The medicine is intended exclusively for cutaneous use, meaning it is applied directly to the surface of the skin. It is available as a cream or ointment in a 2% strength, with the cream formulation often noted as appropriate for use on weeping or macerated lesions and in skin folds.

Official Dosing and Frequency

The standard regimen involves applying a thin layer of the preparation gently over the affected area. The frequency of application is determined by whether the treated area is covered:

  • Uncovered Lesions: The usual schedule is application three or four times daily.
  • Covered Lesions: If the area is dressed with an occlusive covering, the frequency is often reduced, with once or twice daily application being adequate.

The administration protocol applies the same dosing regimen to both the adult and paediatric populations.

Duration and Administration Context

Treatment duration is strictly time-bound, with the overall course typically lasting seven to 14 days. The treatment must not exceed 14 days to help mitigate the risk of developing antimicrobial resistance. Procedural guidance requires that contact with the eyes must be avoided due to the potential for irritation from excipients. For women who are breastfeeding, it is recommended to avoid application to the breast area.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Fuci Top 2%

Evidence for Use in Primary Bacterial Skin Infections

Research exploring the use of Fuci Top 2% (Fusidic Acid) in primary skin infections such as impetigo and folliculitis has mainly relied on Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These short-term trials were used in research exploring how symptoms change over time, often measuring outcomes related to measured changes in clinical status and lesion appearance, as well as the time it takes for healing. The study populations often included patients across all age groups, with a notable focus on children.

The findings describe patterns observed in the studies related to the infection status. Research highlights changes measured during the study period, with studies monitoring how symptoms evolved in the observed populations. When compared against a non-active cream (placebo), studies examined measured changes in clinical outcomes. Scientific reviews noted that the evidence quality varies across studies due to differences in how the findings were reported, and long-term outcomes are not well characterized.


Evidence for Use in Secondary Bacterial Skin Infections

Research examining Fuci Top 2% in situations where a chronic skin condition, such as eczema, develops a secondary bacterial presence has also been evaluated through Systematic Reviews that look at relevant RCTs. These studies evaluated conditions characterized by heightened symptom activity due to bacterial colonization. Outcomes linked to inflammatory or irritative states were monitored, including measured changes in the secondary infection status and patterns of reduction in the number of susceptible bacteria observed on the skin.

What remains uncertain is the full relationship between the medicine’s use and the underlying skin condition. The research has examined short-term changes in the infection itself. Data for the long-term management of the underlying skin condition (like eczema) remain insufficient. Furthermore, scientific literature highlights an ongoing concern regarding the potential for bacterial resistance to develop.


Comparator and Placebo-Controlled Evidence

Studies have explored how the observed outcomes of Fuci Top 2% compare to both an inactive formulation and other common treatments. Randomized Controlled Trials were conducted to examine the observed patterns of change when this medicine was used versus other established topical antibiotics and, in some cases, oral antibiotics. Comparative studies have explored whether findings were mixed when compared to certain other treatments. The overall evidence quality varies across studies due to methodological differences, and certainty remains low for comparative evidence in some contexts.

Key Studies & References

  1. Impetigo: antimicrobial prescribing (NG153) - NICE Guideline
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fuci Top 2% (FAQ)


Q: Is Fuci Top 2% the same as other similar creams?

According to official documents, the active ingredient, Fusidic Acid, is classified as belonging to the fusidane class of antibiotics. This classification reflects its specific chemical structure, which is distinct from many other common topical antibiotics. The preparation typically contains only the one primary medicinal ingredient, Fusidic Acid.


Q: Can Fuci Top 2% be used on all parts of the body?

The preparation is approved for cutaneous use, meaning it is meant for application only on the surface of the skin. Official regulatory information emphasizes that contact with the eyes must be avoided due to the potential for irritation. Additionally, if you are breastfeeding, use of the cream on the breast area should be avoided to prevent accidental infant ingestion.


Q: What should I do if the side effects seem severe?

Regulatory patient information describes serious signs of hypersensitivity, such as sudden swelling of the face or throat (Angioedema) or a severe allergic reaction (Anaphylaxis), as rare adverse events. Official patient guidance describes that in the event of a severe reaction, the product should be discontinued, and the patient should seek immediate medical attention.


Q: Can Fuci Top 2% be used for acne?

The officially approved therapeutic uses are for primary bacterial skin infections like impetigo and folliculitis, and for secondary infections occurring alongside chronic skin conditions. Acne is not listed among the primary approved therapeutic indications in regulatory documentation for this product. A healthcare provider determines the appropriateness of the treatment.


Q: Why do doctors prescribe Fuci Top 2% instead of pills?

The medicine is intended for use at the site of a skin infection, and official studies show that it results in negligible systemic exposure. This means very little of the medicine enters the bloodstream. This means that the preparation is designed to act primarily in the treated area, as its negligible systemic exposure limits entry into the bloodstream.


Q: Does Fuci Top 2% contain steroids?

The active ingredient, Fusidic Acid, is chemically classified as a steroidal antibiotic, referring to its specific chemical structure. Official product information indicates that this preparation contains only the antibiotic, and does not contain an added corticosteroid.


Q: What is the difference between an ointment and a cream version of this medication?

Both the cream and ointment forms contain the same active ingredient. Regulatory documents describe the cream formulation as often being appropriate for use on lesions that are weeping or macerated (wet or broken down) and for application within skin folds. The ointment is typically used for drier or scaly lesions.


Q: Can I use Fuci Top 2% near my eyes or mouth?

Official labeling states that contact with the eyes must be avoided due to the risk of irritation. Furthermore, official labeling states that an excipient present in the formulation may cause localized irritation if applied to mucous membranes (such as the mouth or lips).


Q: How do I know if the condition I have can be treated with Fuci Top 2%?

The medicine is approved for addressing skin problems that are caused by susceptible bacteria. Official therapeutic indications include infections such as impetigo and folliculitis, as well as bacterial presence that develops secondary to other skin conditions. The final appropriateness of the treatment for any specific condition is assessed and determined by a healthcare provider.


Q: What kind of bacteria is Fuci Top 2% effective against?

Official documentation indicates that the medicine is effective against a range of Gram-positive organisms. This primarily includes different species of Staphylococcus, notably the common pathogen Staphylococcus aureus. The preparation is designed to act against these susceptible bacteria by halting their growth.


Q: Are there any long-term side effects associated with using Fuci Top 2%?

Official warnings state that prolonged or recurrent use of the preparation is associated with certain risks. Official warnings state that these risks include the development of bacterial antibiotic resistance and the development of contact sensitization (a local allergic reaction).


Q: How is the safety profile of Fuci Top 2% determined?

The safety profile is established by regulatory bodies through a thorough review of evidence. This evidence includes findings from clinical trials and ongoing monitoring from post-marketing surveillance once the drug is in use. This process leads to the official classification of documented side effects by their frequency.


Q: Does Fuci Top 2% affect birth control pills?

According to official regulatory documents and patient information, the active ingredient is not known to affect the efficacy of hormonal contraception, including birth control pills. This absence of interaction is due to the negligible systemic absorption that occurs when the product is applied topically to the skin.


Q: What happens if I forget to use Fuci Top 2% one time?

Official patient guidance advises that if a scheduled application is missed, the user should apply the medicine as soon as the missed dose is remembered. Official patient guidance indicates the regular application routine should be continued thereafter.


Q: Does Fuci Top 2% need a prescription?

In many regulatory regions, official classifications designate this medicine as a Prescription Only Medicine (POM). This means that the preparation generally requires a prescription from a qualified healthcare professional before it can be legally dispensed to a patient.


Q: What is the typical shelf life of Fuci Top 2%?

The official shelf life for the unopened tube is typically noted in regulatory documentation as 36 months (3 years). The shelf life is based on the product being stored according to the temperature and environmental requirements stated on the packaging.

Advertisements

How should Fuci Top 2% be stored and disposed of?

How to Store and Dispose of Fuci Top 2% (Fusidic Acid 2% Cream)

Official regulatory documents define specific, non-advisory rules for the storage and disposal of this topical antibiotic, primarily focusing on stability and safety.


Storage and Stability Requirements

  • Temperature: The medicine must be stored at a temperature not exceeding 25°C.
  • Child Protection: The product must be kept out of the sight and reach of children.
  • Stability After Opening: Any unused portion of the cream must be discarded 20 days after the tube is first opened.

Disposal Instructions

  • Wastewater and Household Waste: Do not dispose of the medicine via wastewater or general household waste.
  • Procedure: Patients must ask the pharmacist for the correct procedure to dispose of unused or expired cream, ensuring the method helps protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fuci Top 2% found in:

A-Z Index: